- 現金殖利率: 2.55%、總殖利率: 2.55%、5年平均現金配發率: 90.89%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 1.53 | -70.58 | 1.30 | -74.0 | 0.00 | 0 | 84.97 | -11.63 | 0.00 | 0 | 84.97 | -11.63 |
2022 (9) | 5.20 | -12.46 | 5.00 | -7.41 | 0.00 | 0 | 96.15 | 5.77 | 0.00 | 0 | 96.15 | 5.77 |
2021 (8) | 5.94 | 132.03 | 5.40 | 125.0 | 0.00 | 0 | 90.91 | -3.03 | 0.00 | 0 | 90.91 | -3.03 |
2020 (7) | 2.56 | 26.11 | 2.40 | 33.33 | 0.00 | 0 | 93.75 | 5.73 | 0.00 | 0 | 93.75 | 5.73 |
2019 (6) | 2.03 | -21.01 | 1.80 | -28.0 | 0.00 | 0 | 88.67 | -8.85 | 0.00 | 0 | 88.67 | -8.85 |
2018 (5) | 2.57 | -21.17 | 2.50 | -16.67 | 0.00 | 0 | 97.28 | 5.71 | 0.00 | 0 | 97.28 | 5.71 |
2017 (4) | 3.26 | -12.13 | 3.00 | -14.29 | 0.00 | 0 | 92.02 | -2.45 | 0.00 | 0 | 92.02 | -2.45 |
2016 (3) | 3.71 | 6.92 | 3.50 | 9.37 | 0.00 | 0 | 94.34 | 2.3 | 0.00 | 0 | 94.34 | 2.3 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 0.56 | -48.62 | 12.0 | 0.57 | -45.71 | 54.05 | 2.21 | 33.13 | 57.86 |
24Q2 (19) | 1.09 | 94.64 | 78.69 | 1.05 | 128.26 | 110.0 | 1.66 | 196.43 | 84.44 |
24Q1 (18) | 0.56 | 300.0 | 93.1 | 0.46 | 109.09 | 58.62 | 0.56 | -63.64 | 93.1 |
23Q4 (17) | 0.14 | -72.0 | -36.36 | 0.22 | -40.54 | -21.43 | 1.54 | 10.0 | -71.05 |
23Q3 (16) | 0.50 | -18.03 | -53.27 | 0.37 | -26.0 | -54.32 | 1.40 | 55.56 | -72.55 |
23Q2 (15) | 0.61 | 110.34 | -69.5 | 0.50 | 72.41 | -71.75 | 0.90 | 210.34 | -77.67 |
23Q1 (14) | 0.29 | 31.82 | -85.71 | 0.29 | 3.57 | -84.41 | 0.29 | -94.55 | -85.71 |
22Q4 (13) | 0.22 | -79.44 | -85.53 | 0.28 | -65.43 | -81.33 | 5.32 | 4.31 | -12.07 |
22Q3 (12) | 1.07 | -46.5 | -47.29 | 0.81 | -54.24 | -59.09 | 5.10 | 26.55 | 12.58 |
22Q2 (11) | 2.00 | -1.48 | 24.22 | 1.77 | -4.84 | 10.62 | 4.03 | 98.52 | 61.2 |
22Q1 (10) | 2.03 | 33.55 | 128.09 | 1.86 | 24.0 | 113.79 | 2.03 | -66.45 | 128.09 |
21Q4 (9) | 1.52 | -25.12 | 97.4 | 1.50 | -24.24 | 80.72 | 6.05 | 33.55 | 133.59 |
21Q3 (8) | 2.03 | 26.09 | 123.08 | 1.98 | 23.75 | 117.58 | 4.53 | 81.2 | 148.9 |
21Q2 (7) | 1.61 | 80.9 | 117.57 | 1.60 | 83.91 | 142.42 | 2.50 | 180.9 | 174.73 |
21Q1 (6) | 0.89 | 15.58 | 394.44 | 0.87 | 4.82 | 480.0 | 0.89 | -65.64 | 394.44 |
20Q4 (5) | 0.77 | -15.38 | 208.0 | 0.83 | -8.79 | 277.27 | 2.59 | 42.31 | 26.34 |
20Q3 (4) | 0.91 | 22.97 | 0.0 | 0.91 | 37.88 | 0.0 | 1.82 | 100.0 | 0.0 |
20Q2 (3) | 0.74 | 311.11 | 0.0 | 0.66 | 340.0 | 0.0 | 0.91 | 405.56 | 0.0 |
20Q1 (2) | 0.18 | -28.0 | 0.0 | 0.15 | -31.82 | 0.0 | 0.18 | -91.22 | 0.0 |
19Q4 (1) | 0.25 | 0.0 | 0.0 | 0.22 | 0.0 | 0.0 | 2.05 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 1.77 | -2.33 | 0.83 | 21.69 | 17.56 | 5.79 | N/A | - | ||
2024/9 | 1.81 | -17.59 | 0.48 | 19.92 | 19.32 | 6.57 | 0.91 | - | ||
2024/8 | 2.2 | -13.79 | 8.04 | 18.1 | 21.6 | 7.45 | 0.8 | - | ||
2024/7 | 2.55 | -5.47 | 25.45 | 15.9 | 23.75 | 7.91 | 0.75 | - | ||
2024/6 | 2.7 | 1.66 | 33.99 | 13.35 | 23.43 | 7.91 | 0.74 | - | ||
2024/5 | 2.66 | 4.07 | 25.23 | 10.65 | 20.99 | 7.53 | 0.78 | - | ||
2024/4 | 2.55 | 9.84 | 20.47 | 7.99 | 19.63 | 6.38 | 0.92 | - | ||
2024/3 | 2.32 | 54.6 | 10.41 | 5.44 | 19.24 | 5.44 | 1.09 | - | ||
2024/2 | 1.5 | -6.62 | 15.33 | 3.11 | 26.77 | 4.68 | 1.27 | - | ||
2024/1 | 1.61 | 2.57 | 39.67 | 1.61 | 39.67 | 4.83 | 1.23 | - | ||
2023/12 | 1.57 | -5.13 | 8.68 | 21.67 | -31.62 | 4.98 | 1.23 | - | ||
2023/11 | 1.65 | -5.81 | 3.34 | 20.1 | -33.54 | 5.22 | 1.18 | - | ||
2023/10 | 1.76 | -2.67 | -5.0 | 18.45 | -35.6 | 5.6 | 1.1 | - | ||
2023/9 | 1.8 | -11.4 | -15.27 | 16.69 | -37.71 | 5.88 | 1.09 | - | ||
2023/8 | 2.04 | 0.09 | -11.94 | 14.89 | -39.65 | 6.09 | 1.05 | - | ||
2023/7 | 2.03 | 0.95 | -17.11 | 12.85 | -42.52 | 6.17 | 1.04 | - | ||
2023/6 | 2.02 | -4.98 | -32.95 | 10.81 | -45.66 | 6.26 | 1.14 | - | ||
2023/5 | 2.12 | 0.11 | -39.44 | 8.8 | -47.91 | 6.35 | 1.13 | - | ||
2023/4 | 2.12 | 0.67 | -42.42 | 6.68 | -50.12 | 5.53 | 1.3 | 全球景氣下滑,終端需求不振致營收減少。 | ||
2023/3 | 2.1 | 61.5 | -42.59 | 4.56 | -53.04 | 4.56 | 1.84 | 全球景氣下滑,終端需求不振致營收減少。 | ||
2023/2 | 1.3 | 13.07 | -58.91 | 2.46 | -59.37 | 3.9 | 2.16 | 全球景氣下滑,終端需求不振致營收減少。 | ||
2023/1 | 1.15 | -20.18 | -59.88 | 1.15 | -59.88 | 4.2 | 2.0 | 全球景氣下滑,終端需求不振致營收減少。 | ||
2022/12 | 1.44 | -9.79 | -46.6 | 31.69 | -11.49 | 4.89 | 1.91 | - | ||
2022/11 | 1.6 | -13.44 | -42.95 | 30.25 | -8.62 | 5.58 | 1.67 | - | ||
2022/10 | 1.85 | -13.16 | -46.61 | 28.65 | -5.44 | 6.29 | 1.48 | - | ||
2022/9 | 2.13 | -7.92 | -38.26 | 26.8 | -0.12 | 6.9 | 1.37 | - | ||
2022/8 | 2.31 | -5.78 | -30.95 | 24.67 | 5.5 | 7.78 | 1.22 | - | ||
2022/7 | 2.46 | -18.33 | -25.72 | 22.36 | 11.59 | 8.97 | 1.05 | - | ||
2022/6 | 3.01 | -14.18 | -7.62 | 19.9 | 18.97 | 10.19 | 0.77 | - | ||
2022/5 | 3.5 | -4.83 | 9.24 | 16.9 | 25.39 | 10.85 | 0.72 | - | ||
2022/4 | 3.68 | 0.4 | 22.01 | 13.39 | 30.44 | 10.52 | 0.74 | - | ||
2022/3 | 3.67 | 15.59 | 29.23 | 9.71 | 33.95 | 9.71 | 0.78 | - | ||
2022/2 | 3.17 | 10.42 | 58.04 | 6.04 | 36.98 | 8.75 | 0.87 | 受惠於全球半導體晶片荒持續發酵,主要產品線營收均較去年同期增長。 | ||
2022/1 | 2.87 | 6.2 | 19.4 | 2.87 | 19.4 | 8.38 | 0.9 | - | ||
2021/12 | 2.7 | -3.61 | 3.64 | 35.81 | 23.49 | 8.97 | 0.78 | - | ||
2021/11 | 2.81 | -19.0 | 5.52 | 33.1 | 25.45 | 9.72 | 0.72 | - | ||
2021/10 | 3.46 | 0.4 | 14.66 | 30.3 | 27.68 | 10.27 | 0.68 | - | ||
2021/9 | 3.45 | 2.97 | 14.78 | 26.83 | 29.59 | 10.11 | 0.6 | - | ||
2021/8 | 3.35 | 1.35 | 18.86 | 23.38 | 32.1 | 9.91 | 0.61 | - | ||
2021/7 | 3.31 | 1.57 | 21.36 | 20.03 | 34.61 | 9.77 | 0.62 | - | ||
2021/6 | 3.25 | 1.48 | 24.01 | 16.73 | 37.58 | 9.48 | 0.5 | - | ||
2021/5 | 3.21 | 6.29 | 27.83 | 13.47 | 41.32 | 9.06 | 0.53 | - | ||
2021/4 | 3.02 | 6.34 | 30.8 | 10.27 | 46.13 | 7.86 | 0.61 | - | ||
2021/3 | 2.84 | 41.36 | 40.97 | 7.25 | 53.63 | 7.25 | 0.59 | 受惠於中國經濟復甦及耳溫槍、遠距視訊相關產品需求成長,加上去年第一季新冠肺炎爆發需求急凍,基期較低。 | ||
2021/2 | 2.01 | -16.57 | 33.44 | 4.41 | 63.04 | 7.02 | 0.61 | 受惠於中國經濟復甦及耳溫槍、遠距視訊相關產品需求成長,加上去年2月新冠肺炎爆發需求急凍,基期較低。 | ||
2021/1 | 2.41 | -7.81 | 100.07 | 2.41 | 100.07 | 7.67 | 0.56 | 受惠於中國經濟復甦及耳溫槍、視訊相關產品需求成長,加上去年1月為農曆春節,基期較低。 | ||
2020/12 | 2.61 | -1.86 | 57.97 | 29.0 | 10.06 | 8.29 | 0.44 | 受惠於中國經濟復甦,加上因疫情而導致耳溫槍及遠距視訊相關產品需求強勁成長。 | ||
2020/11 | 2.66 | -11.96 | 35.49 | 26.39 | 6.86 | 8.69 | 0.42 | - | ||
2020/10 | 3.02 | 0.48 | 34.44 | 23.73 | 4.38 | 8.84 | 0.41 | - | ||
2020/9 | 3.01 | 6.65 | 46.03 | 20.71 | 1.09 | 8.55 | 0.48 | - | ||
2020/8 | 2.82 | 3.49 | 25.61 | 17.7 | -3.93 | 8.17 | 0.51 | - | ||
2020/7 | 2.72 | 3.77 | -3.64 | 14.88 | -8.03 | 7.86 | 0.53 | - | ||
2020/6 | 2.62 | 4.59 | 2.2 | 12.16 | -8.95 | 7.44 | 0.64 | - | ||
2020/5 | 2.51 | 8.77 | -12.53 | 9.53 | -11.61 | 6.83 | 0.69 | - | ||
2020/4 | 2.31 | 14.61 | -12.21 | 7.03 | -11.27 | 5.82 | 0.81 | - | ||
2020/3 | 2.01 | 33.81 | -13.58 | 4.72 | -10.81 | 4.72 | 1.04 | - | ||
2020/2 | 1.5 | 25.06 | 5.4 | 2.71 | -8.63 | 4.36 | 1.12 | - | ||
2020/1 | 1.2 | -27.2 | -21.68 | 1.2 | -21.68 | 4.82 | 1.02 | - | ||
2019/12 | 1.65 | -15.82 | -7.92 | 26.34 | -7.39 | 0.0 | N/A | - | ||
2019/11 | 1.96 | -12.65 | -2.0 | 24.69 | -7.35 | 0.0 | N/A | - |